Beatriz Palacios-Izquierdo
Nessuna posizione attualmente
Storia della carriera di Beatriz Palacios-Izquierdo
Precedenti posizioni note di Beatriz Palacios-Izquierdo
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Traslational Cancer Drugs Pharma SL
 Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Corporate Officer/Principal | - | - |
| ALMIRALL, S.A. | Corporate Officer/Principal | - | - |
Chemo Ibérica SA
 Chemo Ibérica SA Pharmaceuticals: MajorHealth Technology Chemo Ibérica SA develops and distributes pharmaceutical products. It also produces veterinery finished products, raw materials, intermediate products from synthesis and other fine chemicals. Its activities are grouped under chemistry, generics, healthcare, veterinery and agrochemicals. The company also operates in India, China, Italy, Guatemala, Switzerland, Hungary, Argentina, Belgium & Luxembourg through subsidiaries, joint ventures and commercial offices. Chemo Iberica was founded in 1977 and is headquartered in Madrid, Spain. | Direttore Tecnico/Scientifico/R&S | - | - |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - | - |
Formazione di Beatriz Palacios-Izquierdo
| University of Salamanca | Doctorate Degree |
Statistiche
Distribuzione geografica
| Spagna | 5 |
| Svizzera | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| ALMIRALL, S.A. | Health Technology |
| Aziende private | 3 |
|---|---|
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Chemo Ibérica SA
Chemo Ibérica SA Pharmaceuticals: MajorHealth Technology Chemo Ibérica SA develops and distributes pharmaceutical products. It also produces veterinery finished products, raw materials, intermediate products from synthesis and other fine chemicals. Its activities are grouped under chemistry, generics, healthcare, veterinery and agrochemicals. The company also operates in India, China, Italy, Guatemala, Switzerland, Hungary, Argentina, Belgium & Luxembourg through subsidiaries, joint ventures and commercial offices. Chemo Iberica was founded in 1977 and is headquartered in Madrid, Spain. | Health Technology |
Traslational Cancer Drugs Pharma SL
Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Health Technology |
